Next generation programmable cancer gene therapies

Research unit

INNOSUISSE

Project number

120.389 IP-LS

Project title

Next generation programmable cancer gene therapies

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	Pattern BioSciences develops first-in-class gene therapies using its innovative technology platform that combines synthetic biology and biomolecular computing. Together with research partner A. Moor from ETH, this project will expand its pipeline with an R&D program in metastatic colorectal cancer.